The largest database of trusted experimental protocols

659 protocols using au5800

1

Fasting Blood Biomarker Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Fasting blood samples of all patients were taken from the antecubital vein after an overnight fasting period of at least 8 h. Biochemical parameters were studied from plasma samples. Plasma glucose levels were measured using the enzymatic reference method with hexokinase (Beckman Coulter AU5800), and plasma HbA1c levels were measured by high-performance liquid chromatography (HPLC) and mass spectroscopy method (Premier HB9210). Low-density lipoprotein (LDL) was measured using enzymatic colorimetric assay (Beckman Coulter AU5800), and plasma creatinine was assessed using the kinetic Jaffé method (Beckman Coulter AU5800). Urine protein level was measured by the protein error of indicator method (IQ 200/iChem velocity).
+ Open protocol
+ Expand
2

Analytical Performance of Immunoassay Tests

Check if the same lab product or an alternative is used in the 5 most similar protocols
Precision studies were performed in qualitative (one-point calibration against cutoff calibrator) and semi-quantitative (five-point calibration) modes on the Beckman Coulter AU480, AU680, AU5800, and DxC 700 AU clinical analyzers. Cross-reactivity: Cross-reactivity studies were performed in qualitative and semi-quantitative modes on the Beckman Coulter AU480, AU680, AU5800, and DxC 700 AU clinical analyzers. Proof-of-principle cross-reactivity testing was performed and crossreactivity was similar across all four analyzer platforms. Method Comparison: Method comparison studies were performed in qualitative and semi-quantitative modes on the Beckman Coulter AU480, AU680, AU5800, and DxC 700 AU clinical analyzers. Clinical samples containing hydrocodone and hydromorphone were confirmed by LC/MS.
+ Open protocol
+ Expand
3

Comprehensive Metabolic Profiling in Adults

Check if the same lab product or an alternative is used in the 5 most similar protocols
BMI was calculated by the standard formula [BMI = weight (kg) / height (m 2 )]. The systolic blood pressure (SBP) and diastolic blood pressure (DBP) were measured after 15 min of rest using a mercury sphygmomanometer [17] . Following overnight fasting, blood samples were obtained from all participants through venipuncture. Fasting plasma glucose (FPG), triglycerides (TG), total cholesterol (TC), low density lipoproteincholesterol (LDL-C), high density lipoprotein-cholesterol (HDL), alanine aminotransferase (ALT), aspartate aminotransferase (AST), and serum creatinine (Scr) were measured using an automatic biochemistry analyzer (AU5800; Beckman Coulter, America). The estimated glomerular filtration rate (GFR) was calculated as the endogenous creatinine clearance using the Cockcroft equation for males: GFR = [140 -age (years) * body weight (kg)] / [0.818 * Scr (µmol/L)]. The GFR was multiplied by 0.85 for females. HbA1c (Glycated Hemoglobin, Type A1c) was determined using high-performance liquid chromatography (HA-8180; ARKRAY, Japan). The urinary albumin concentration was measured by immunophelometry (AU5800; Beckman Coulter, America). The urinary albumin-to-creatinine ratio (ACR) was determined as ACR = urine albumin (mg) / urine creatinine (g). All measurements were repeated twice.
+ Open protocol
+ Expand
4

Metabolic Biomarker Profiling in Fasting Participants

Check if the same lab product or an alternative is used in the 5 most similar protocols
Blood samples will be obtained from participants’ antecubital vein in a supine position during the morning in a fasting state. Blood parameters will include insulin, glucose, triglycerides, total cholesterol, high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), alanine transaminase (ALT), and γ-glutamyl transferase (γ-GT). Glucose levels will be measured by spectrophotometric techniques (AU5800, Beckman Coulter, Brea, California, USA). Insulin will be assessed by chemiluminescence immunoassay with paramagnetic particles (UniCel DxI 800, Beckman Coulter, Brea, California, USA). Triglycerides, total cholesterol, and HDL-C will be automatically evaluated by spectrophotometric techniques (AU5800, Beckman Coulter, Brea, California, USA). LDL-C will be considered as (Total cholesterol)  (HDLC)  0.45  (Triglycerides) . ALT and γ-GT will be calculated by absorption spectrophotometric techniques (Beckman Coulter, Brea, California, USA). Insulin glucose ratio (insulin/glucose), LDL-C/HDL-C ratio (LDL-C/HDL-C), and triglycerides/HDL-C ratio (triglycerides/HDL-C) will also be determined.
+ Open protocol
+ Expand
5

Biomarkers for Acute Coronary Syndrome

Check if the same lab product or an alternative is used in the 5 most similar protocols
Plasma fasting blood glucose (FBG), triglyceride (TG), high‐density lipoprotein cholesterol (HDL‐C), and LDL cholesterol (LDL‐C) concentrations were measured by standard laboratory procedures in an automatic biochemistry analyzer (AU5800; Beckman Coulter) using detection kits (Beckman Coulter). In addition, plasma CK‐MB, myoglobin (MYO), and high‐sensitive cardiac troponin I (hs‐cTnI) were measured by a UniCel DxI 800 analyzer (Beckman Coulter) with commercial detection kits (Beckman Coulter).
For this study, we used archived plasma samples of healthy controls and patients with ACS that had been frozen at −80°C and never previously thawed. The determination of sd‐LDL‐C concentrations was performed by a fully automated homogeneous method (Denka Seiken Co., Ltd.) in an automated biochemistry analyzer (AU5800; Beckman Coulter) as previously described.20The ratio of sd‐LDL‐C/LDL‐C was calculated as measured sd‐LDL‐C (mmol/L)/ LDL‐C (mmol/L).18 All the laboratory measurements of patients with ACS and healthy subjects were under no treatment after admission.
+ Open protocol
+ Expand
6

Standardized Biomarker Measurements for Epidemiological Studies

Check if the same lab product or an alternative is used in the 5 most similar protocols
The NHS and NHSII heparinized plasma samples were assayed for total cholesterol, HDL-C, direct LDL-C, and triglycerides using an ARCHITECT ci8200 analyzer (Abbott Diagnostics, Chicago IL). High-sensitivity C-reactive protein (CRP) levels were measured via a validated immunoturbidometric method (Denka Seiken, Tokyo, Japan) (20 (link)). Matched case-control sets were assayed together in the same batch. Coefficients of variation (CVs) calculated from blinded replicate samples randomly interspersed with participant samples were ≤2% across all assay batches. These biomarkers are stable within person over time, with intraclass correlations over 1 year of 0.60–0.84 (21 (link)). In the UK Biobank, assays were performed at a dedicated central laboratory between 2014 and 2017, including measurement of serum total cholesterol, HDL-C, direct LDL-C, and triglycerides (Beckman Coulter AU5800). High-sensitivity CRP was measured by immunoturbidimetric analysis (Beckman Coulter AU5800). CVs for the UK Biobank assays were ≤3% across all assay batches (https://biobank.ndph.ox.ac.uk/showcase/showcase/docs/serum_biochemistry.pdf).
+ Open protocol
+ Expand
7

Urine and Blood Biomarker Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Urine was collected by participants using containers designed by the researchers and was stored at +4 °C in the refrigerator before measurement. Blood samples were collected by trained nurses. After being centrifuged, all the blood samples were stored at −20 °C in the refrigerator before measurement. Urine and plasma osmolality were measured with the method of the freezing point using an osmotic pressure molar concentration meter (SMC 30C, Tianhe, Tianjin, China).
The electrolyte concentrations of sodium, potassium, chloride, calcium, magnesium, and phosphate in the urine and blood were assessed using an automatic biochemical analyzer (AU5800, Beckman, Brea, CA, USA) with the ion-selective electrode potentiometer method. Urine specific gravity (USG) was tested with the uric dry-chemistry method by a trained technician using an automatic urinary sediment analyzer (H-800, Dirui, Jilin, China).
Blood glucose (BG) was measured with an automatic biochemical analyzer (AU5800, Beckman, Brea, CA, USA), with the ion-selective electrode potentiometer method.
+ Open protocol
+ Expand
8

Kidney Oxidative Stress Measurements

Check if the same lab product or an alternative is used in the 5 most similar protocols
A total of 90 min after the left kidney was exposed by laparotomy, 5 ml of blood was drawn from the inferior vena cava and collected into heparinized tubes. Serum urea and creatinine levels were measured by a spectrophotometric method using a commercial kit (Beckman Coulter® AU 5800, USA). Blood urea nitrogen (BUN) levels were calculated from urea values. The serum levels of tumor necrosis factor-alpha (TNF-α) and cystatin C (Cys C) were determined via enzyme-linked immunosorbent assay using commercial kits (BioVendor, Brno, Czech Republic and Invitrogen, Camarillo, CA, USA). All assays were studied twice, and the mean value was recorded.
A half of the left kidney was washed with 0.9% NaCl and stored at −80°C until homogenization. Kidney tissues were homogenized with 1:10 phosphate tamponade at two steps using a homogenizer (Janke and Kunkel Ultra-Turrax® T25, Germany) and a sonicator (UW-2070, Bandelin Electronic GmbH and Co, Germany). The total antioxidant status (TAS) and total oxidant status (TOS) of the tissues were analyzed using status assay kits (Reel Assay Diagnostics, Turkey) in accordance with the modified Erel method.[7 (link),8 (link)] Protein levels of the homogenates were measured using spectrophotometry (Beckman Coulter® AU 5800, USA). TAS and TOS results were expressed as mmol Trolox Eq/gr and μmol H2O2 Eq/gr, respectively.
+ Open protocol
+ Expand
9

Biomarker Assessment in Longitudinal Study

Check if the same lab product or an alternative is used in the 5 most similar protocols
At the initial assessment (2006-2010), blood and spot urine samples were collected and analyzed at a centralized laboratory. Sampling, handling, and quality control of biochemical measures have been described in detail previously (25 (link)). Briefly, serum creatinine, urine creatinine and urine albumin were measured on a Beckman Coulter AU5800 instrument. An enzymatic, IDMS-traceable method was used to measure serum and urine creatinine. Urine albumin was quantified using an immune-turbidimetric method (Randox laboratories) with a lower limit of detection of 6.7 mg/L. Measurements below the lower limit of detection were set to 6.7 mg/L as done previously (26 (link)). Serum cystatin C was measured using an Immuno-turbidimetric assay on a Siemens ADVIA 1800 instrument. Estimated GFR was calculated using creatinine (eGFRcre) or cystatin C (eGFRcys) by the CKD-EPI equation as described previously (27 (link),28 (link)). SUA was measured by uricase PAP analysis on a Beckman Coulter AU5800.
+ Open protocol
+ Expand
10

Serum Biomarkers in Clinical Assessments

Check if the same lab product or an alternative is used in the 5 most similar protocols
After BP measurements, participants remained in the seated position and blood samples were drawn via venipuncture from a vein in the antecubital fossa using a disposable cannula (S-Monovette, Sarstedt, Nürmbrecht, Germany). After collection, blood samples were immediately processed and transported to the diagnostic laboratories of the University Hospital Erlangen for further analyses. Blood samples were used to determine serum concentrations of fasting glucose, triglycerides, total cholesterol, low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C) and liver biochemistry (alanine aminotransferase (ALT), aspartate aminotransferase (AST) and gamma glutamyl transpeptidase (GGT)), which were measured photometrically (Clinical Chemistry Analyzer AU700 or AU5800, Beckman Coulter, Brea, CA, USA), and high-sensitivity C-reactive protein (hsCRP) and glycated hemoglobin A1c (HbA1c) using turbidimetric immunoassays (Clinical Chemistry Analyzer AU700 or AU5800, Beckman Coulter, Brea, CA, USA, and COBAS Integra 400, Roche Diagnostics, Mannheim, Germany, respectively).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!